CCIXUHIGH SIGNALFINANCIAL10-K

CCIXU experienced a severe deterioration in financial position with current assets collapsing by over 90% while stockholder deficit deepened substantially.

The dramatic decline in current assets from $2.8M to just $162K indicates severe liquidity constraints for this SPAC, potentially threatening its ability to complete a business combination or fund operations. The widening stockholder deficit to -$10.1M reflects mounting losses and operational cash burn during the search for acquisition targets.

Comparing 2026-02-05 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

CCIXU's financial position deteriorated markedly during the period, with current assets falling precipitously from $2.8M to $162K, representing a critical liquidity squeeze. The stockholder deficit expanded meaningfully to -$10.1M, indicating continued operational losses and mounting financial pressure. This financial profile suggests the SPAC is facing significant cash constraints that could impair its ability to execute its business combination strategy.

FINANCIAL STATEMENT CHANGES
Current Assets
Balance Sheet
-94.3%
$2.8M→$162K

Current assets declined 94.3% — monitor working capital adequacy and short-term liquidity.

Stockholders Equity
Balance Sheet
-41.2%
-$7.1M→-$10.1M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

LANGUAGE CHANGES
NEW — 2026-02-05
PRIOR — 2025-03-31
ADDED
As of February 5, 2026, there were 29,475,000 Class A Ordinary Shares, par value $0.0001 per share, and 7,187,500 Class B Ordinary Shares, par value $0.0001 per share, of the registrant issued and outstanding.
Form 10-K Summary 50 SIGNATURES i CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Report (as defined below), including, without limitation, statements under Part II, Item 7.
These forward-looking statements can be identified by the use of forward-looking terminology, including the words believe, estimate, anticipate, expect, intend, plan, may, will, potential, project, predict, continue, should, could or would or, in each case, their negative or other variations or comparable terminology.
domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 as provided for by the Inflation Reduction Act of 2022; FASB are to the Financial Accounting Standards Board; First PlusAI Merger Agreement Amendment are to Amendment No.
Securities and Exchange Commission; SEC Clawback Rule are to Rule 10D-1 under the Exchange Act; Second PlusAI Merger Agreement Amendment are to Amendment No.
+7 more — sign up free →
REMOVED
As of March 28 , 2025, there were 29,475,000 Class A Ordinary Shares, par value $0.0001 per share, and 7,187,500 Class B Ordinary Shares, par value $0.0001 per share, of the registrant issued and outstanding.
These forward-looking statements can be identified by the use of forward-looking terminology, including the words believes, estimates, anticipates, expects, intends, plans, may, will, potential, projects, predicts, continue, or should, or, in each case, their negative or other variations or comparable terminology.
In addition, the SEC s adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act (as defined below), including its duration, asset composition, business purpose, and the activities of the SPAC and its management team.
The 2024 SPAC Rules may materially affect our ability to negotiate and complete our initial Business Combination and may increase the costs and time related thereto.
Overview We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →